Open Access
Cancer Science, volume 109, issue 8, pages 2391-2400
Resistin facilitates metastasis of lung adenocarcinoma through the TLR 4/Src/ EGFR / PI 3K/ NF ‐κB pathway
Wei-Jing Gong
1, 2
,
Jun-Yan Liu
3
,
Jiajia Cui
1
,
Di Xiao
4
,
Wei Zhuo
1
,
Chao Luo
1
,
Rui Jie Liu
5
,
Xi Li
1
,
Wei Zhang
1
,
Hong-Hao Zhou
1
,
Publication type: Journal Article
Publication date: 2018-07-20
Journal:
Cancer Science
scimago Q1
SJR: 1.625
CiteScore: 9.9
Impact factor: 4.5
ISSN: 13479032, 13497006
PubMed ID:
29927028
Cancer Research
Oncology
General Medicine
Abstract
Metastasis is the main cause of lung cancer-related death. The tumor microenvironment greatly contributes to tumor metastasis. Resistin, mainly secreted by tumor-associated macrophages in tumor tissues, is a 12.5-kDa cysteine-rich secretory protein that is found at significantly higher levels in the serum or plasma of cancer patients compared with healthy controls. In this study, we explored the expression and role of resistin in lung adenocarcinoma. Our study showed that resistin was strongly expressed in lung adenocarcinoma tissues and promoted the migration and invasion of lung adenocarcinoma cells in a dose-dependent manner. Toll-like receptor 4 (TLR4) was the functional receptor of resistin for migration and invasion in A549 cells. Src/epidermal growth factor receptor (EGFR) was involved in resistin-induced migration and invasion. Resistin increased the phosphorylation of EGFR through the TLR4/Src pathway. We also found that PI3K/nuclear factor (NF)-κB were the intracellular downstream effectors mediating resistin-induced migration and invasion. Taken together, our results suggested that resistin promoted lung adenocarcinoma metastasis through the TLR4/Src/EGFR/PI3K/NF-κB pathway.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.